×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look Out for
Zacks Investment Research
Syros Pharmaceuticals (SYRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming...
15 hours ago
After 2 partners walk away, Syros cuts 35% of workforce and lines up new CEO
Fierce Biotech
A few weeks after a second company walked away from Syros Pharmaceuticals, the biotech is laying off 35% of staff and sharpening its focus...
7 months ago
What Makes Syros Pharmaceuticals, Inc. (SYRS) a New Buy Stock
Yahoo Finance
Syros Pharmaceuticals, Inc. (SYRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to...
3 months ago
Syros Pharmaceuticals Sets Ambitious Timeline for Tamibarotene Regulatory Submission in MDS
Precision Medicine Online
NEW YORK – After undergoing restructuring due to limited cash flow in 2023, Syros Pharmaceuticals is laser focused on bringing its late-stage...
1 month ago
SYRS (Syros Pharmaceuticals) Momentum Rank
GuruFocus
SYRS (Syros Pharmaceuticals) Momentum Rank as of today (April 26, 2024) is 3. Momentum Rank explanation, calculation, historical data and more.
5 days ago
Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why
Nasdaq
Syros Pharmaceuticals, Inc. SYRS shares have skyrocketed 200% in the past three months compared with the industry's rise of 13.1%.
3 months ago
Syros Highlights Anticipated 2024 Milestones to Deliver on the Value of Tamibarotene
Business Wire
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of...
3 months ago
SYRS Stock Quote Price and Forecast
CNN
View Syros Pharmaceuticals, Inc. SYRS stock quote prices, financial information, real-time forecasts, and company news from CNN.
1 month ago
Syros's tamibarotene receives fast track status for AML treatment
Pharmaceutical Technology
Syros Pharmaceuticals has received fast track designation from the FDA for tamibarotene to treat acute myeloid leukaemia.
3 weeks ago
Painful week for private equity firms invested in Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) after 11% drop, institutions also suffered losses
Simply Wall Street
Painful week for private equity firms invested in Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) after 11% drop, institutions also suffered losses.
1 month ago